Metabolism
Serine/threonine kinase AMPK upregulates glucose uptake by promoting the expression and function of glucose transporters. AMPK is activated by increased AMP/ATP ratio, resulting from cellular and environmental stress, e.g. low glucose, heat shock, hypoxia and ischemia. AMPK activation positively modulates signaling transductions that refill ATP levels. Moreover, it also stimulates catabolic processes such as fatty acid oxidation and glycolysis through inhibition of ACC and activation of PFK2. AMPK negatively regulates various proteins which are important to ATP-consuming mechanisms, e.g. mTORC2, glycogen synthase, SREBP-1, and TSC2, causing the downregulation/inhibition of gluconeogenesis and glycogen, lipid and protein synthesis.
- B5448 CP 316819Summary: Selective glycogen phosphorylase inhibitor
- B5503 GPi 688Summary: glycogen phosphorylase inhibitor
- B5508 Alda 1Target: Aldehyde DehydrogenasesSummary: ALDH2 activator
- B5521 LY 78335Summary: phenylethanolamine-N-methyltransferase (PNMT) inhibitor
- B5562 TC-F 2Summary: FAAH inhibitor
- B5581 SR 1664Summary: inhibits Cdk5-mediated PPARγ phosphorylation, antidiabetic agent
- B5599 Fatostatin ASummary: sterol regulatory element binding protein (SREBP) inhibitor
- B5616 GPBAR-ASummary: agonist of bile acid receptor GPBAR1
- B5630 PiclamilastSummary: PDE4 inhibitor
- B5642 TC-E 5005Summary: PDE10A inhibitor